LaViv FDA Approval History
FDA Approved: Yes (First approved June 21, 2011)
Brand name: LaViv
Generic name: azficel-T
Company: Fibrocell Science, Inc.
Treatment for: Wrinkles
Azficel-T is an autologous cellular product indicated for improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults.
Development Timeline for LaViv
|Jun 22, 2011||Approval Fibrocell Science, Inc. Announces FDA Approval for laViv (azficel-T)|
|Jan 12, 2011||Fibrocell Science, Inc. Announces FDA Accepts for Review Complete Response Submission for Azficel-T|
|Dec 20, 2010||Fibrocell Science, Inc. Submits Complete Response to FDA Regarding Azficel-T|
|Dec 22, 2009||Fibrocell Science, Inc. Receives FDA Complete Response Letter Regarding azficel-T for Wrinkles|
|Oct 12, 2009||Fibrocell Science, Inc. Reports Outcome of FDA Advisory Committee Meeting on Azfibrocel-T for Wrinkles|
|May 12, 2009||Food and Drug Administration Accepts Isolagen's Biologics License Application for Full Review|
|Mar 9, 2009||Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.